Leon Research

Executive Summary

Leon Research is a Spanish Contract Research Organization (CRO) and pharmaceutical consulting firm founded in 2005 and headquartered in Madrid. The company offers end-to-end clinical research and regulatory services for medicinal products, medical devices, in-vitro diagnostics, nutritional supplements, and cosmetics across Europe. With direct operational presence in Spain, Italy, and Portugal, Leon Research supports clients throughout the clinical development lifecycle—from strategic trial design to post-marketing surveillance. The firm's comprehensive capabilities position it as a reliable partner for life science companies seeking to navigate European regulatory pathways and conduct multi-country clinical studies. As a privately held company with no disclosed funding rounds or valuation, Leon Research operates as a nimble, specialized CRO in the competitive European market. Its long-standing presence since 2005 and focus on diverse product categories—including both pharmaceuticals and consumer health—demonstrate adaptability and deep regulatory expertise. While the company lacks recent public announcements about major trial wins or expansions, its established footprint in key Southern European markets provides a stable foundation for growth. Upcoming catalysts could include new contract announcements from biotech clients, expansion into adjacent therapeutic areas, or strategic partnerships to enhance digital health capabilities.

Upcoming Catalysts (preview)

• Q3 2026Major Contract Win with Biotech Sponsor60% success
• Q4 2026Expansion into New European Markets (e.g., France, Germany)40% success
• Q1 2027Partnership with Digital Health Platform for Decentralized Trials30% success